These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 27072026)
1. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells. Zhang W; Wang F; Wang Y; Wang J; Yu Y; Guo S; Chen R; Zhou D J Control Release; 2016 Jun; 232():9-19. PubMed ID: 27072026 [TBL] [Abstract][Full Text] [Related]
2. Glutathione detonated and pH responsive nano-clusters of Au nanorods with a high dose of DOX for treatment of multidrug resistant cancer. Wang Y; Wang F; Liu Y; Xu S; Shen Y; Feng N; Guo S Acta Biomater; 2018 Jul; 75():334-345. PubMed ID: 29885528 [TBL] [Abstract][Full Text] [Related]
3. pH, redox and photothermal tri-responsive DNA/polyethylenimine conjugated gold nanorods as nanocarriers for specific intracellular co-release of doxorubicin and chemosensitizer pyronaridine to combat multidrug resistant cancer. Wang Y; Zhang Z; Xu S; Wang F; Shen Y; Huang S; Guo S Nanomedicine; 2017 Jul; 13(5):1785-1795. PubMed ID: 28185939 [TBL] [Abstract][Full Text] [Related]
4. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
5. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy. Miao D; Yu Y; Chen Y; Liu Y; Su G Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274 [TBL] [Abstract][Full Text] [Related]
6. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy. Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893 [TBL] [Abstract][Full Text] [Related]
7. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells. Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205 [TBL] [Abstract][Full Text] [Related]
8. Near-infrared light-triggered thermochemotherapy of cancer using a polymer-gold nanorod conjugate. Ko H; Son S; Bae S; Kim JH; Yi GR; Park JH Nanotechnology; 2016 Apr; 27(17):175102. PubMed ID: 26987360 [TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy. Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751 [TBL] [Abstract][Full Text] [Related]
10. Gold nanorods with phase-changing polymer corona for remotely near-infrared-triggered drug release. Liu J; Detrembleur C; Grignard B; De Pauw-Gillet MC; Mornet S; Treguer-Delapierre M; Petit Y; Jérôme C; Duguet E Chem Asian J; 2014 Jan; 9(1):275-88. PubMed ID: 24347074 [TBL] [Abstract][Full Text] [Related]
11. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449 [TBL] [Abstract][Full Text] [Related]
12. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells. Zhong Y; Wang C; Cheng L; Meng F; Zhong Z; Liu Z Biomacromolecules; 2013 Jul; 14(7):2411-9. PubMed ID: 23701318 [TBL] [Abstract][Full Text] [Related]
13. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
14. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
15. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance. Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203 [TBL] [Abstract][Full Text] [Related]
16. Chemo/Photoacoustic Dual Therapy with mRNA-Triggered DOX Release and Photoinduced Shockwave Based on a DNA-Gold Nanoplatform. Zang Y; Wei Y; Shi Y; Chen Q; Xing D Small; 2016 Feb; 12(6):756-69. PubMed ID: 26683002 [TBL] [Abstract][Full Text] [Related]
17. Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux. Daglioglu C J Pharm Sci; 2018 Mar; 107(3):934-941. PubMed ID: 29107049 [TBL] [Abstract][Full Text] [Related]
18. A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer. Jiang Y; Guo Z; Fang J; Wang B; Lin Z; Chen ZS; Chen Y; Zhang N; Yang X; Gao W Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110224. PubMed ID: 31761194 [TBL] [Abstract][Full Text] [Related]
19. Redox-responsive hyaluronic acid nanogels for hyperthermia- assisted chemotherapy to overcome multidrug resistance. Li B; Xu Q; Li X; Zhang P; Zhao X; Wang Y Carbohydr Polym; 2019 Jan; 203():378-385. PubMed ID: 30318226 [TBL] [Abstract][Full Text] [Related]
20. Peptide Multifunctionalized Gold Nanorods with Dual pH/NIR Responsive Release of Doxorubicin for High-Efficiency Cancer Treatment. Wang J; Ma K; Wang H; Hu Z; Fu Y; Li F J Biomed Nanotechnol; 2019 Nov; 15(11):2164-2178. PubMed ID: 31847931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]